The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples

被引:4
|
作者
Peng, Hongwei [1 ]
Pan, Ming [2 ]
Zhou, Zongning [1 ]
Chen, Congbo [3 ]
Xing, Xing [4 ]
Cheng, Shaoping [4 ]
Zhang, Shanshan [1 ]
Zheng, Hang [5 ]
Qian, Kaiyu [1 ,5 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Urol Dis,Dept Biol Repositories, Wuhan, Peoples R China
[2] Hubei Univ Med, Taihe Hosp, Taihe Skills Training Ctr, Shiyan, Hubei, Peoples R China
[3] Hubei Univ Med, Taihe Hosp, Dept Urol, Shiyan, Hubei, Peoples R China
[4] Yangtze Univ, Affiliated Hosp 1, Dept Urol, Jingzhou, Hubei, Peoples R China
[5] Wuhan Univ, Zhongnan Hosp, Dept Urol, Lab Precis Med, Wuhan, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2024年 / 12卷
关键词
cell-free DNA (cfDNA); preanalytical variables; standardization; blood; urine; CIRCULATING TUMOR DNA; FREE PLASMA DNA; LIQUID BIOPSY; COLLECTION TUBES; COMMERCIAL KITS; NUCLEIC-ACIDS; CANCER DIAGNOSTICS; LUNG-CANCER; DIGITAL PCR; SERUM;
D O I
10.3389/fcell.2024.1385041
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell-free DNA (cfDNA), a burgeoning class of molecular biomarkers, has been extensively studied across a variety of biomedical fields. As a key component of liquid biopsy, cfDNA testing is gaining prominence in disease detection and management due to the convenience of sample collection and the abundant wealth of genetic information it provides. However, the broader clinical application of cfDNA is currently impeded by a lack of standardization in the preanalytical procedures for cfDNA analysis. A number of fundamental challenges, including the selection of appropriate preanalytical procedures, prevention of short cfDNA fragment loss, and the validation of various cfDNA measurement methods, remain unaddressed. These existing hurdles lead to difficulties in comparing results and ensuring repeatability, thereby undermining the reliability of cfDNA analysis in clinical settings. This review discusses the crucial preanalytical factors that influence cfDNA analysis outcomes, including sample collection, transportation, temporary storage, processing, extraction, quality control, and long-term storage. The review provides clarification on achievable consensus and offers an analysis of the current issues with the goal of standardizing preanalytical procedures for cfDNA analysis.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Cell-free DNA and the monitoring of lymphoma treatment
    Camus, Vincent
    Jardin, Fabrice
    PHARMACOGENOMICS, 2019, 20 (18) : 1271 - 1282
  • [22] Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics
    van Ginkel, Joost H.
    van den Broek, Daan A.
    van Kuik, Joyce
    Linders, Dorothe
    de Weger, Roel
    Willems, Stefan M.
    Huibers, Manon M. H.
    CANCER MEDICINE, 2017, 6 (10): : 2297 - 2307
  • [23] The art of obtaining a high yield of cell-free DNA from urine
    Augustus, Elien
    Van Casteren, Kaat
    Sorber, Lauri
    van Dam, Peter
    Roeyen, Geert
    Peeters, Marc
    Vorsters, Alex
    Wouters, An
    Raskin, Jo
    Rolfo, Christian
    Zwaenepoel, Karen
    Pauwels, Patrick
    PLOS ONE, 2020, 15 (04):
  • [24] Circulating cell free DNA: Preanalytical considerations
    El Messaoudi, Safia
    Rolet, Fanny
    Mouliere, Florent
    Thierry, Alain R.
    CLINICA CHIMICA ACTA, 2013, 424 : 222 - 230
  • [25] Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR
    Rosing, Fabian
    Meier, Matthias
    Schroeder, Lea
    Laban, Simon
    Hoffmann, Thomas
    Kaufmann, Andreas
    Siefer, Oliver
    Wuerdemann, Nora
    Klussmann, Jens Peter
    Rieckmann, Thorsten
    Alt, Yvonne
    Faden, Daniel L.
    Waterboer, Tim
    Hoefler, Daniela
    MICROBIOLOGY SPECTRUM, 2024, 12 (07)
  • [26] Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis
    Zancan, Matelda
    Galdi, Francesca
    Di Tonno, Fulvio
    Mazzariol, Chiara
    Orlando, Claudio
    Malentacchi, Francesca
    Agostini, Marco
    Maran, Michela
    Del Bianco, Paola
    Fabricio, Aline S. C.
    Murer, Bruno
    Pianon, Carlo
    Gion, Massimo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (03) : 147 - 155
  • [27] Preanalytical Variables in the Analysis of Mitochondrial DNA in Whole Blood and Plasma from Pancreatic Cancer Patients
    Randeu, Hannah
    Bronkhorst, Abel J.
    Mayer, Zsuzsanna
    Oberhofer, Angela
    Polatoglou, Eleni
    Heinemann, Volker
    Haas, Michael
    Boeck, Stefan
    Holdenrieder, Stefan
    DIAGNOSTICS, 2022, 12 (08)
  • [28] Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine
    Pages, Melanie
    Rotem, Denisse
    Gydush, Gregory
    Reed, Sarah
    Rhoades, Justin
    Ha, Gavin
    Lo, Christopher
    Fleharty, Mark
    Duran, Madeleine
    Jones, Robert
    Becker, Sarah
    Haller, Michaela
    Sinai, Claire E.
    Goumnerova, Liliana
    Golub, Todd R.
    Love, J. Christopher
    Ligon, Keith L.
    Wright, Karen D.
    Adalsteinsson, Viktor A.
    Beroukhim, Rameen
    Bandopadhayay, Pratiti
    NEURO-ONCOLOGY, 2022, 24 (08) : 1352 - 1363
  • [29] Cell-free DNA as a biomarker in cancer
    Eibl, Robert H.
    Schneemann, Markus
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2022, 3 (03): : 195 - 215
  • [30] A rapid purification method for trace amounts of cell-free DNA in urine
    Fukushima, Ryo
    Ogura, Yuina
    Hosokawa, Chikako
    Watanabe, Noriko
    Ishikawa, Fumihiro
    Shibanuma, Motoko
    Kato, Masaru
    ANALYTICAL SCIENCES, 2025, 41 (02) : 137 - 143